dc.contributor.author | Bliss, J | |
dc.contributor.author | Kernaghan, S | |
dc.contributor.author | Fribbens, C | |
dc.contributor.author | Stevenson, L | |
dc.contributor.author | Morden, J | |
dc.contributor.author | Snowdon, C | |
dc.contributor.author | Macpherson, I | |
dc.contributor.author | Wardley, A | |
dc.contributor.author | Roylance, R | |
dc.contributor.author | Baird, R | |
dc.date.accessioned | 2017-10-24T10:55:12Z | |
dc.date.issued | 2017-05-08 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000410814200114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | TRIALS, 2017, 18 pp. ? - ? (1) | |
dc.identifier.issn | 1745-6215 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/873 | |
dc.format.extent | ? - ? (1) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | BIOMED CENTRAL LTD | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Medicine, Research & Experimental | |
dc.subject | Research & Experimental Medicine | |
dc.title | The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010) | |
dc.type | Other | |
rioxxterms.funder | The Institute of Cancer Research | |
rioxxterms.identifier.project | Unspecified | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2017-05-08 | |
rioxxterms.type | Other | |
dc.relation.isPartOf | TRIALS | |
pubs.declined | 2017-10-11T11:58:39.80+0100 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.publication-status | Published | |
pubs.volume | 18 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical Trials & Statistics Unit | en_US |
dc.contributor.icrauthor | Kernaghan, Sarah | en |
dc.contributor.icrauthor | Morden, James Peter | en |
dc.contributor.icrauthor | Bliss, Judith | en |
dc.contributor.icrauthor | Snowdon, Claire | en |